GOLDMAN SACHS GROUP INC - SIO GENE THERAPIES INC ownership

SIO GENE THERAPIES INC's ticker is SIOX and the CUSIP is 829399104. A total of 52 filers reported holding SIO GENE THERAPIES INC in Q4 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of SIO GENE THERAPIES INC
ValueSharesWeighting
Q4 2021$22,000
-90.4%
17,355
-83.5%
0.00%
Q3 2021$228,000104,9000.00%
Other shareholders
SIO GENE THERAPIES INC shareholders Q4 2021
NameSharesValueWeighting ↓
Tower View Wealth Management LLC 11,645$1,348,0001.02%
Cladis Investment Advisory, LLC 552,000$155,0000.20%
Rubric Capital Management LP 7,000,000$1,960,0000.10%
Newtyn Management, LLC 1,500,000$420,0000.09%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,914,000$1,656,0000.07%
ACT CAPITAL MANAGEMENT, LLC 146,500$41,0000.06%
Clearline Capital LP 392,691$110,0000.01%
Hudson Bay Capital Management LP 1,680,536$471,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 105,400$30,0000.00%
WOLFF WIESE MAGANA LLC 2,400$1,0000.00%
View complete list of SIO GENE THERAPIES INC shareholders